Role of Low-Substituted Hydroxypropylcellulose in Dissolution and Bioavailability of Novel Fine Granule System for Masking Bitter Taste
スポンサーリンク
概要
- 論文の詳細を見る
Coated fine granules with water-insoluble film composed primarily of ethylcellulose, containing 20% of sparfloxacin (SPFX) and various amounts of low-substituted hydroxypropylcellulose (L-HPC) (0-52%) in the cores and which masked the bitter taste of SPFX, were orally administered to fasting rats to determine the effect of L-HPC on bioavailability. The release of SPFX in water from four kinds of these coated fine granules containing 0,25,40 and 52% of L-HPC showed the pseudo first order kinetics, followed by the second phase, with refractive points between 0.25 and 0.5 h. The rate constant (K_1) up to 0.25 h increased with an increase in of the amount of L-HPC in the core, and the rate constant (K_2) in subsequent release (the second phase) was lower than K_1 in each fine granule. Areas under plasma concentration-time curves (AUC) of SPFX and the peak plasma SPFX levels (C_<max>) after oral administration of coated fine granules lacking L-HPC to fasting rats were suppressed to one-eighth and one-ninth, respectively, of those obtained from the core granules that rapidly released SPFX. However, AUC and C_<max> from the coated fine granules increased linearly with an increase in the amount of L-HPC in the cores, and nearly equaled those from the core fine granules when the content of L-HPC was 52%. These results confirmed that the addition of L-HPC to the cores increases not only the dissolution rate but also the bioavailability of SPFX.
- 社団法人日本薬学会の論文
- 1994-03-15
著者
-
中村 康彦
大日本製薬株式会社製品研究所
-
藤岡 弘
大日本製薬・製品研究所
-
白井 寿海
大日本製薬株式会社製品研究所
-
十川 清己
大日本製薬・製品研究所
-
白井 寿海
Pharmaceutical Research Laboratories, Dainippon Pharmaceutical Co., Ltd.
-
十川 清己
Pharmaceutical Research Laboratories, Dainippon Pharmaceutical Co., Ltd.
-
藤岡 弘
Pharmaceutical Research Laboratories, Dainippon Pharmaceutical Co., Ltd.
-
中村 康彦
Pharmaceutical Research Laboratories, Dainippon Pharmaceutical Co., Ltd.
関連論文
- 難溶性薬物である脳血管障害治療薬(AJ-3941)の固体分散体顆粒の調製とその評価
- テープ接着法による素錠の接着強度とフィルム接着性の評価
- 溶解度積を用いた注射剤の輸液との配合性予測
- 破壊型速溶性コーチング散の苦味マスクと溶出への崩壊剤と熱処理の影響
- サイリウムハスクを用いたマトリックス錠からの薬物放出挙動
- Role of Low-Substituted Hydroxypropylcellulose in Dissolution and Bioavailability of Novel Fine Granule System for Masking Bitter Taste
- A Novel Fine Granule System for Masking Bitter Taste
- Particle Design of Enoxacin by Spherical Crystallizaion Technique. II. Characteristics of Agglomerated Crystals
- Particle Design of Enoxacin by Spherical Crystallization Technique. I. : Principle of Ammonia Diffusion System (ADS)
- Influence of Specific Gravity and Food on Movement of Granules in the Gastrointestinal Tract of Rats
- 糖衣錠の経時的な着色の原因と対策
- Movement of Granules and Tablets in the Gastrointestinal Tract of Gastric-Emptying-Controlled Rabbits
- 凍結乾燥注射剤の溶状不良の原因
- Controlled Release by Ca^-Sensitive Recombinant Human Tumor Necrosis Factor-α Liposomes
- Cryoprotective Effect of Gelatin and Albumin on Recombinant Human Tumor Necrosis Factor Liposome
- ニトロフラン誘導体のシステイン, 消化管内容物および光に対する安定性
- 螢光法によるニトロフラン誘導体の定量
- 苦味をマスクした膜破壊型コーティング細粒の製剤設計に関する研究 : スパルフロキサシン細粒の製剤化
- Design of Novel Controlled-Release Suppositories Containing Polyglycerol Ester of Fatty Acid
- Influence of Solid Fat Index in Triglyceride Suppository Bases on Drug Release
- 苦みのマスキングと徐放製剤
- 第20回粉体に関する討論会